GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,654 | -28.5% | 22,600 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $119,878 | +20.1% | 21,796 | -6.1% | 0.00% | 0.0% |
| Q1 2023 | $99,799 | +11.6% | 23,209 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $89,396 | -26.1% | 22,747 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $121,000 | -15.4% | 22,830 | +4.8% | 0.00% | 0.0% |
| Q2 2022 | $143,000 | -10.6% | 21,775 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $160,000 | -3.0% | 21,754 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $165,000 | -72.5% | 23,285 | -2.9% | 0.00% | -66.7% |
| Q3 2021 | $601,000 | -8.9% | 23,981 | -2.3% | 0.00% | +50.0% |
| Q2 2021 | $660,000 | -1.2% | 24,552 | +4.6% | 0.00% | 0.0% |
| Q1 2021 | $668,000 | +230.7% | 23,483 | +229.0% | 0.00% | +100.0% |
| Q4 2020 | $202,000 | -11.0% | 7,137 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $227,000 | – | 7,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |